Objectives: Tuberculosis (TB) infects over 9 million people annually and, in high prevalence settings, is closely related to HIV/AIDS. Despite this, the two diseases are often treated using contrasting approaches: one focused on patient control, the other focused on empowerment. This article reports on patient experiences of a TB treatment programme in South Africa modelled on the empowerment-oriented antiretroviral treatment (ART) programme.
Introduction
Tuberculosis (TB) kills over 2 million people worldwide each year and infects over 9 million. 1 South Africa has a high burden of TB, 1 plus the highest number of people living with HIV/AIDS in the world -approximately 5.5 million in 2007. 2 In some areas, up to 80% of patients presenting with active TB are also infected with HIV. 3 The standard mode of treatment delivery for TB, directly observed therapy (DOT), has been in place for over a decade. DOT implies that a patient takes their treatment in the presence of a nurse or a dedicated lay treatment supporter. 1 Despite the implementation of DOT, only approximately 74% of smear positive TB patients are treated successfully in South Africa. 1 Several studies from a range of settings have also indicated that DOT may disempower TB patients, by reinforcing unequal power relations between providers and patients and by placing unrealistic demands on patients to adhere to health service requirements. 4 These demands often conflict with both patients' priorities, for example to earn a living, and with the notion that patients should be empowered to take greater responsibility for the management of their illness.
In contrast, antiretroviral treatment (ART) programmes have achieved high adherence rates in sub-Saharan Africa, although in selected populations. 5 The reasons why these ART programmes have been more successful in maintaining adherence, compared to TB programmes, are not entirely clear. In examining the unfolding of the HIV/AIDS epidemic in Sub-Saharan Africa in the early 1990s, Seidel identified two competing discourses: one focusing on 'control and exclusion' and the other using the language of 'rights and empowerment'. 6 As they have expanded, ART programmes in this context have focused on patient empowerment, in part as a consequence of local, national and international action on the part of people living with HIV. 7 In South Africa, this movement was particularly strong due to the perceived need to challenge the government of the time's denialist position on HIV/AIDS and the need to and expand access to treatment. 8 This approach has resulted in people living with HIV in some settings becoming advocates for treatment and seeing themselves as belonging to a global community of people on treatment, with the notion of 'therapeutic citizenship' being used to describe this appropriation of ART as a set of rights and responsibilities. 7 TB management could be said to have remained in the sphere of 'control and exclusion', with a focus on DOT and little emphasis on patient rights, preparation, motivation and social support, in comparison to ART programmes. 9 While both TB and ART programmes include community-based treatment supporters, these are used in TB programmes to implement DOT rather than to support or empower the patient in managing their own treatment. Furthermore, social mobilization around health care and the right to treatment has been largely absent from both activities and discourses around TB, in contrast to the powerful movements that have developed around HIV/AIDS. Empowerment can be seen as a process by which people can gain mastery over their own lives; it can lead either to a sense of control or to practical power to effect change. 10 There is some evidence that empowerment approaches may impact on health outcomes, 11 and it is possible, given the success of ART programmes in maintaining adherence when compared with TB programmes, that the different degrees of patient empowerment in these two programmes might contribute to this difference.
Recognizing the apparent success of the ART programme in Cape Town, and in order to address the low TB treatment success rates in this setting, health services have piloted a treatment approach modelled on the ART programme. Our aim was to explore the impact of the new treatment programme on the lives of people receiving TB treatment.
Methods
A qualitative approach was used as this allowed us to explore the meanings, experiences and views of the participants and to access areas not open to quantitative methods. 12 The study took place in Khayelitsha, an urban settlement on the outskirts of Cape Town and home to 400 000 people, 13 most of whom live in informal dwellings. The average income of residents was less than R1500 (approximately 215 USD) per month in 2006, 14 and crime rates are were high. HIV prevalence rates were 33% in 2004, 15 and TB incidence 1596/100000 in 2006. 16 The Enhanced TB Adherence Programme
The new intervention, the Enhanced Tuberculosis Adherence Programme (ETA), was implemented by the health services in five TB clinics in the Western Cape, in collaboration with a non-governmental organization responsible for managing lay health workers at these sites. The intervention is based on the community ART model, 17 Initially, patients take treatment under supervision of a nurse at a primary care facility. During this time, lay treatment supporters conduct a home assessment to check living conditions, verify the patient's address and identify TB contacts in the home. Patients are also asked to select a 'buddy' -a family member, neighbour or friend to support and motivate the patient during treatment, and to report problems to the health services, where necessary. Patients and their buddies attend three to four intensive counselling sessions on TB and its treatment with a lay adherence counsellor in the first few days after starting treatment. These sessions focus on treatment education, side-effects, healthy living and adherence planning.
After these components are completed, the TB nurse, treatment supporter and adherence counsellor meet to decide a patient's eligibility for the new programme. The eligibility criteria were: first diagnosis of TB, living within the catchment area of the clinic, not having substance use problems or mental illness, having a permanent place to live, and being able to find a treatment buddy. Patients not meeting these criteria were retained on clinic DOT. Patients could also refuse to be part of the programme and opt for treatment at the clinic. If eligible, the patient receives a one month supply of pills, and returns monthly to the clinic for pill collection and monitoring by the nurse. They also return for doctor's appointments and for 2 and 5 month sputa, if applicable. At home, patients mark a specially created treatment calendar each time that they take their pills. The treatment supporter visits them three times in the first week, and once a week thereafter to monitor their progress through checking calendars and pill counts. Table 1 shows a comparison of the key components of the intervention and the standard DOT TB treatment models. This paper reports on one part of a larger programme evaluation. 18 
Participants and sampling
Participants were recruited by lay health workers from two selected intervention clinics and by nurses from the one clinic implementing DOT (comparison clinic). We chose to include participants from a comparison clinic implementing DOT, rather than from among those patients receiving DOT at the intervention clinics, to explore differences and similarities between the two programmes. Participant demographics are presented in Table 2 .
Data collection
Focus groups were used to explore norms; people's experiences, beliefs, wishes and concerns; and for allowing participants to interact and discuss issues. 19 These If patients choose to, they may take DOT in the workplace or at a clinic. If they opt for the new treatment model, they receive a one month supply of tablets from the clinic and self-supervise their treatment at home. If at any time they default treatment, they are recalled to clinic-based treatment Nurse sees patient at diagnosis, for DOT, for 2/3 month sputum and at the end of treatment Nurse sees patient at diagnosis, DOT for two weeks and, if the patient is eligible for self-supervision, once per month until end of treatment (for treatment collection and sputum testing) If the patient is placed on community-based DOT, the patient visits a treatment supporter in his/her community once a day for treatment
If the patient is placed on self-supervision, a community-based treatment supporter visits the patient once a week to conduct pill counts and check for problems that may affect adherence to treatment There is no formal integration of family or friends into the treatment plan
The treatment 'buddy' has an important role -he/she attends the counselling sessions and provides day-to-day support to the patient regarding treatment. The buddy can be a friend, family member or neighbour of the patient data were supplemented with individual interviews with two patients who had been non-adherent. Men and women were included in separate focus groups given the sensitive nature of the topic; the dynamics between the sexes within the study setting; and the potential for sex-based differences in adherence and health seeking behaviour when infected with TB. 20 We conducted groups at intervention and comparison sites until we considered the data saturated. The groups were moderated by an experienced moderator in Xhosa (the local language), at a venue outside the clinic. More people arrived for those groups conducted during weekends, which explains some of the differences in group sizes across intervention and comparison sites. The discussion guide focused on participants' general experience of TB; experiences of health services; and support during TB treatment. During all the groups, only two people chose to leave. The guides were modified as we discovered gaps in the data that needed further exploration. The interview guide used with the two patients who had defaulted from treatment was similar to the one used in the groups, but focused more on reasons for stopping treatment.
All groups and interviews were audio-recorded, transcribed and translated from Xhosa to English. Translations were checked for accuracy and discrepancies corrected. We analysed data concurrently with data collection and conducted further groups to explore emerging categories.
Data analysis
We analysed data using content analysis as the study progressed. 21 We considered the unit of analysis as the transcript from a group or interview. First, the transcripts were read, re-read and coded inductively into meaning units. When independent coding was complete, the results were compared and discussed by the authors. Any discrepancies were resolved through this process. Meaning units were entered into a table (Table 3) , where condensed meaning units were developed. Data were then coded into codes, sub-categories, and categories. These categories were presented to all authors for agreement, together with selected data extracts. The categories and data extracts were discussed and refined until authors reached consensus. Analysis was conducted by two independent analysts (SA, DB) Analysis was informed by data from the other aspects of the programme evaluation, 18 including interviews with programme staff. Validity was increased through the use of multiple analysts, 22 and ongoing discussion among all of the authors regarding the findings. 23 A challenge to validity is that we worked from translated text. We attempted to counter this by close discussion with the focus group moderator.
Results
We found three main themes: a tension between agency and coercion in treatment taking; treatment as a lifestyle change; and the role of the supporter as constraining or facilitating empowerment.
Agency and coercion in treatment taking
Many intervention group participants cited their reasons for remaining on treatment as taking responsibility for their health, 'loving themselves' and taking care of themselves. In this they may have been echoing the information they received during treatment counselling. However, participants in all groups discussed making a decision to keep taking treatment and the wish to remain healthy, with participants in the intervention groups emphasising this more: 'I think people should learn to value themselves and their lives and then they will not stop taking their treatment. People have to love themselves so much that they do not need [a] caregiver to run after them to take their treatment' (female, intervention). Agency was also evident in patients' descriptions of their lifestyle changes, with these seemingly being fuelled by their desire to look after their own health.
While participants discussed the importance of taking responsibility and control over one's health and treatment, their suggestions for how to ensure that others adhered to TB treatment were at times extremely coercive. These suggestions included hospitalization, making patients go to the clinic every day and grinding tablets into patients' food: 'I think that the people who are residing with the stubborn patient should make sure that the 
Treatment as a lifestyle change
Intervention counselling, focused on adherence planning and on healthy living beyond TB treatment, was a key element of the programme. A participant summarized the information given as: '. . .you should not smoke, you should not drink and you should not default your treatment' (male, intervention).
Intervention participants seemed to see lifestyle change as important to successful treatment completion, reporting that they had given up drinking, smoking and other 'misbehaviour': 'When I started to take my treatment I use to 'steal' alcohol. I knew that on Sunday and Saturday we do not take treatment and therefore that is my free time to do whatever, meaning drinking . . .but my treatment supporter caught up on that, and now I follow the treatment the way I'm supposed to' (female, intervention).
Participants suggested that others who did not take their treatment, acted in this way because they were not prepared to give up their old lifestyles: 'Another thing is that other people do not want to give up on their lifestyle, for example drinking' (male, intervention and did not complete treatment). They seemed to attach a moral value to being able to adhere to the suggestions of the adherence counsellor and those who did not do so were perceived as 'bad' individuals. Participants also suggested the lifestyle changes demanded of them by the programme were difficult and that, when feeling better, people returned to their previous ways of living: 'I think when people start feeling better they go back to their old habits' (male, intervention). Supporting this claim, one participant reported: 'then friends would come over and ask me to take a glass maybe of beer or maybe a smoke and tell me that a glass won't kill me. I ended up drinking and smoking again and that made me lazy to go to the clinic' (male, non-adherent).
Participants from the comparison clinic spoke less of changes to their day-to-day lives, with the only reference to alcohol use: '. . .some of us did not sleep at home last night -we were drinking. And next when you have a hangover you cannot handle the smell of the treatment and the more you drink, [the more] you prolong your recovering process. I think people need to be educated about the importance of treatment, and also the danger that he/she puts [him/herself] in while he/ she is drinking alcohol' (male, comparison). Participants in comparison clinics may have received less information during their treatment about lifestyle changes.
Participants in intervention groups thought that their lifestyles were in general healthier now than before treatment: 'My life has changed for the better. . .now I know I have to look after my health everyday. . . my daily life has been affected in a very good way' (female, intervention).
They had also constructed routines around their treatment taking, with one man noting that: 'I wake up and take my pills, then clean and then eat . . .' (male, intervention). Overall, participants who received the new programme saw treatment as being more than the consumption of pills. Rather, it was seen as including changes in their patterns of daily living and as a moral project, in which 'good' patients would participate.
The role of the supporter: constraining or facilitating empowerment?
In both intervention and comparison groups, there seemed to be a continuum of responses to the roles of lay treatment supporters and buddies. Some participants reported being very independent, whereas others seemed to rely more on their buddies and on treatment supporters. Having TB meant that patients now had to allow another person into their lives as a treatment supporter and also needed to select a buddy from their household.
This seemed to change their relationships and roles within the household from member of the family to someone to be taken care of. Across intervention and comparison groups, treatment supporters were initially treated with suspicion. Some participants felt that they were there to feed local gossip: 'I was very rude and difficult to my treatment supporter the first day because . . .I thought she was visiting to check how bad I was so that she can "publish" her story' (female, intervention). It was unclear whether these initial negative views towards treatment supporters were related to patients' anxieties regarding the stigma attached to TB and HIV or to their fear of other 'indiscretions' being made known in their community. Many intervention participants reported that a supportive relationship was established once they recognized that the treatment supporter cared for them and had a strong interest in their successful treatment completion: '. . . she cares about me and she is like a parent to me because in this day and age no else cares if you have taken you treatment or not' (female, intervention). Female participants, in particular, emphasized this aspect of the relationship, while men were firmer in their desire to be independent of treatment support. The views expressed of treatment supporters being caring could also be a consequence of patients accepting that treatment supporters were an unavoidable part of the treatment regimen prescribed by the clinic. Indeed, most participants' reported that their discussions with treatment supporters centred on TB and treatment rather than on other aspects of their daily lives: '(laughing) we do not talk about my personal life' (female, did not complete treatment).
Treatment supporters were either seen as motivators who supported patients in taking their treatment or as playing a role in monitoring participants and identifying defaulters. However, these supporters were generally seen in a more positive light than community DOT supporters. For example, participants in a male comparison group noted the importance of taking control over their treatment from the DOT supporter: 'I think we also have to take responsibility and take control because we know how many pills we get from the doctor, and when you get to the treatment supporter you also need to take control and ask for the amount of pills that you need to be taking as per doctor's instruction' (male, comparison). They also perceived community DOT supporters as incompetent and gossipy and saw the journey to reach DOT supporters as inconvenient. Instead they thought that treatment supporters should visit them in their homes. Female participants in comparison clinics were more accommodating towards their DOT supporters but there was still an element of resignation: '. . .you need to get along' (female, comparison).
Most intervention participants reported that they appreciated the motivation and encouragement that they received from their buddies: '. . .the way my family has been supportive is amazing' (female, intervention), with some buddies also assisting with issues such as food and money. It was notable that the two participants who had stopped taking treatment reported some problem with their buddy: 'When I was still at home with my mother [buddy], she used to help me with my treatment but you know how we males are. . ..' (male, non-adherent). Participants in comparison clinics also reported that their families supported their treatment, indicating an informal buddy system. However, a few participants also mentioned that friends or family had encouraged them to stop treatment: '. . . My friends are telling me to stop dosing myself. . .' (female, intervention).
One participant noted that a buddy may have a limited role in adherence and emphasized his own role and independence from this form of support: '. . .the person in the room [referring to his buddy] doesn't really have a problem with whether I take my pills or not. She asks me after three days if I take my treatment TB and I told myself I'm the one who has TB [and] therefore need to take my treatment everyday . . .' (male, intervention). Some also felt that support was constrained by the patientbuddy relationship and that their relationship with their buddy had deteriorated: 'My relationship with my sister was fine before my TB treatment but it got to change. Now I get to be angry at her for asking me to take my medication. At times I wish they could go back to their house in Caledon [a small town near Cape Town]. . .' (female, intervention). For other participants, their buddies had taken on a supervisory role in treatment: '. . .she does not only remind me to take my treatment but makes me drink [it] right in front of her' (male, intervention). This approach could be seen as conflicting with the ethos of the new treatment support programme.
In addition to the categories reported above, participants reported: stigma related to TB and HIV; lay explanations and myths surrounding the disease, such as TB causing HIV; TB as dangerous and fatal; and the type of treatment, in particular pill size and colour, were questioned and lamented. Their responses to diagnosis ranged from guilt, to acceptance and relief.
Discussion
The emphasis placed on lifestyle by those receiving the Enhanced TB Adherence Programme, and the impacts of their TB treatment on this, was striking. However, it remains unclear whether this focus on the wider aspects of the illness was due to patients feeling more empowered to engage with this or was a consequence of simply repeating instructions from health care providers. Many intervention participants reported taking on the advice given to them and implementing changes in their day-to-day lives, including reducing substance use and constructing routines for treatment taking, as noted elsewhere. 24 Given the link between alcohol use and TB, this aspect of the intervention may have beneficial effects beyond TB treatment. 25 Participants did suggest, though, that other TB patients tended to return to their 'old' lifestyles during treatment, potentially contributing to poor treatment completion rates in this setting.
Participants also seemed to attach a moral value to following the advice of health care providers -a person who followed instructions and adhered to treatment was considered a 'good patient', suggesting a dichotomy between the good, adherent and rational self and the deviant and diseased other. 26 Furthermore, participants suggested extremely coercive measures for those who were non-adherent. This suggests that the discourse of control remains powerful in the setting of TB care, extending beyond the clinic and into the surrounding communities.
Participants in both comparison and intervention clinics spoke of responsibility and control and of making decisions to adhere to treatment, with more emphasis on this in the intervention clinics. However, the patient selection criteria established by the health services for the programme (eligible patients needed to have a permanent place to live and not use substances or have a mental illness) could be seen to exclude those groups of patients who are most disempowered and could perhaps most benefit from additional support in the community. While the intention was that the new programme would free up clinic staff time to provide more support to these groups of patients, it is not clear whether this occurred or, indeed, whether this is feasible in a clinic context in which antagonism from health care providers towards people who do not adhere to TB treatment is well described. 4 The context of care and patients' wider social circumstances may also place limits on patient agency. Access to care remains poor in many settings, while the approach of public health in general can be seen as technocratic and 'top-down', with more coercive practices than in clinical care. 27 The ETA is embedded in this public health system and the wider unequal South African society, as are the patients involved in the programme. Any new intervention is likely to have only a limited impact on this wider system. This is substantiated by the findings of the parallel quantitative outcome evaluation, which suggests that TB treatment outcomes for patients in the ETA programme are generally equivalent to, rather than better than, those achieved with DOT. 18 Other indications of patients' limitations in exercising control over treatment included their reports of both buddies and treatment supporters performing a monitoring role, and that at times their relationship with their selected buddies worsened due to their new roles. Having a supporter may be important to adherence, but these networks of support may not always be beneficial if those within them are uninformed about the disease. The programme's formal requirement for a buddy may, in itself, be something that can be considered disempowering because it implies an immediate disclosure of disease to others, which may be problematic where TB stigma is strong. Studies of ART programmes have reported that an obligation to disclose may delay participation in treatment programmes. 28 In the study context, the patient received treatment regardless of having a buddy but could only receive clinic-based DOT. It is possible that instead of empowering patients in the management of their TB treatment, this intervention has shifted surveillance and control of the patient from the clinic to the community and home. 29, 30 One of the key differences between this programme and the ART programme is that there is no limit to the availability of TB treatment, as there has been for ART treatment. 7 It is also not possible, in the TB programme, to delay treatment or to have a process for selecting for treatment those most likely to adhere. There are therefore perhaps fewer incentives for patients to organize themselves to demand treatment rights. In contrast, the field of HIV treatment in South Africa has been characterized by extensive community mobilization. To date, such sources of support and mobilization for TB patients are unusual. The emergence of identities linked closely to living with HIV/AIDS, and which view ART as a set of rights and responsibilities as encapsulated by the concept of therapeutic citizenship, 7 further differentiates TB treatment from the ART programme. Nonetheless, South Africa has recently seen increased activism surrounding TB, especially in the context of the XDR TB epidemic and TB-HIV co-infection. 31 Within this context, patient education or counselling, such as that delivered by the ETA, may be important and useful to patients. However, a number of aspects of patient control remain within this model and it is therefore unlikely that this approach is sufficient to facilitate empowerment in relation to TB treatment. As Laverack has noted, empowerment needs to be sought by those requiring it and not given by others. 32 The limitations of this study include that many of the participants were on other forms of chronic medication, which may have included HIV treatment. They may therefore have encountered a range of other counselling and patient support interventions, affecting their views regarding treatment responsibility and control. To protect participants' privacy and confidentiality, we were unable to document participants' HIV status during the focus groups. In addition, those participants in focus groups were already pre-selected into the programme as those most likely to be able to adhere to treatment and those who volunteered for the groups may have had a more positive impression of services and the programme. However, during the focus groups participants talked openly on a number of treatment issues, including on defaulting, treatment supporter roles and treatment taking, suggesting that we succeeded in capturing a range of responses. While the results of this study apply to a specific setting and intervention in South Africa and should only be generalized to other TB programmes with caution, the study findings shed light on phenomena that are relevant to TB control globally.
Conclusion
Participants in our study had internalized the messages of the TB treatment intervention and spoke at length about responsibility and control over their treatment. However, they appeared to be limited in exercising this control and shaping their lifestyles, both as a consequence of the monitoring role played by treatment supporters and because of wider constraints within the setting of their daily lives and the broader health system. There was no need for patients to demonstrate 'empowerment' to ensure they received treatment. As the main goal of the TB programme is to control and limit disease spread within communities, the ETA approach, despite being modelled on the ART programme, may also have retained elements of control that acted to constrain patient responsibility and agency. Nonetheless, the intervention seems, in part, to have achieved what it set out to do in that it encouraged patients to be better informed about their disease and supported them to attend to their own priorities.
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